Michael MacLean
Finanzdirektor/CFO bei AVIDITY BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Michael MacLean
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Comptroller/Controller/Auditor | - | - |
| Finanzdirektor/CFO | 19.05.2020 | - | |
| VERVE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2021 | - |
| Independent Dir/Board Member | 01.05.2021 | - |
Karriereverlauf von Michael MacLean
Ehemalige bekannte Positionen von Michael MacLean
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AKCEA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 31.08.2017 | 01.04.2020 |
| Finanzdirektor/CFO | 31.08.2017 | 01.04.2020 | |
| PURETECH HEALTH PLC | Finanzdirektor/CFO | 14.09.2015 | 01.08.2017 |
| IRON MOUNTAIN INCORPORATED | Comptroller/Controller/Auditor | 01.10.2012 | 01.07.2014 |
| Corporate Officer/Principal | 01.07.2014 | 01.06.2015 | |
| BIOGEN INC. | Comptroller/Controller/Auditor | 02.10.2006 | 03.11.2010 |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Corporate Officer/Principal | 01.09.1999 | 01.05.2002 |
KPMG International Ltd.
 KPMG International Ltd. Miscellaneous Commercial ServicesCommercial Services KPMG International Ltd. is a global organization of independent professional services firms that provide audit, tax, and advisory services. The private company is based in Canary Wharf, UK, and has subsidiaries in Norway and Thailand. The British company operates in 145 countries and territories with more than 236,000 partners and employees working in member firms around the world. KPMG International is a private English company limited by guarantee and each KPMG member firm is responsible for its own obligations and liabilities. The company was founded in 1987, and William Bruce Thomas has been the CEO of the company since 2017. | Corporate Officer/Principal | - | - |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Comptroller/Controller/Auditor | 14.12.2010 | - |
| ░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Michael MacLean
| Boston College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 11 |
| Vereinigtes Königreich | 2 |
Operativ
| Comptroller/Controller/Auditor | 5 |
| Corporate Officer/Principal | 4 |
| Director of Finance/CFO | 3 |
Sektoral
| Health Technology | 6 |
| Commercial Services | 4 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| HURON CONSULTING GROUP INC. | Commercial Services |
| BIOGEN INC. | Health Technology |
| PURETECH HEALTH PLC | Health Technology |
| IRON MOUNTAIN INCORPORATED | Finance |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| VERVE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
KPMG International Ltd.
KPMG International Ltd. Miscellaneous Commercial ServicesCommercial Services KPMG International Ltd. is a global organization of independent professional services firms that provide audit, tax, and advisory services. The private company is based in Canary Wharf, UK, and has subsidiaries in Norway and Thailand. The British company operates in 145 countries and territories with more than 236,000 partners and employees working in member firms around the world. KPMG International is a private English company limited by guarantee and each KPMG member firm is responsible for its own obligations and liabilities. The company was founded in 1987, and William Bruce Thomas has been the CEO of the company since 2017. | Commercial Services |
- Börse
- Insiders
- Michael MacLean
- Erfahrung
